President Trump and Democratic rival Joe Biden will both rally supporters on Thursday in the critical battleground state of Florida.
President Trump and Democratic rival Joe Biden will both rally supporters on Thursday in the critical battleground state of Florida.
Hello, ladies and gentlemen, and thank you for standing by for GreenTree's third-quarter 2020 earnings conference call. GreenTree's earnings release was distributed earlier today and is available on our IR website at ir.998.com, as well as on PR Newswire services. On the call from GreenTree are Mr. Alex Xu, chairman and chief executive officer; Ms. Selina Yang, chief financial officer; Ms. Megan Huang, vice president of sales and marketing; and Mr.
Service Fulfillment Market is poised to experience spend growth of more than USD 2,808 million between 2020-2024 at a CAGR of over 9.63%.
Indian movie superstar Rajinikanth said Thursday he plans to launch his own political party in southern India in January, ending years of speculation by millions of his fans on his political future. Rajinikanth, 69, is one of India’s most popular stars with more than 175 films since 1975, mostly in the Tamil and Telugu languages. An announcement on matters connected to the party's launch will be made Dec. 31, he said.
A former rebel commander accused of being involved in the killing of 18 civilians and other crimes that included rape and eating pieces of a school teacher's heart during Liberia's civil war appeared in a Swiss court room on Thursday. The defendant, 45-year-old Alieu Kosiah, denies the charges. Kosiah's crimes are listed by the Swiss court as "recruitment and use of a child soldier, forced transportation, looting, cruel treatment of civilians, attempted murder, murder (directly or by order), desecration of a corpse and rape".
It follows supermarket rivals Morrisons and Tesco, which gave back £850m between them on Wednesday.
Systems®, the future-proof supplier of software tools and services for embedded development, and GigaDevice, an industry-leading semiconductor supplier, announced their powerful solutions for GD32 Arm-based microcontrollers (MCUs). In June 2020, IAR Systems and GigaDevice announced their partnership for RISC-V. This partnership is now extended into delivering development tools for Arm® Cortex®-M3, Cortex-M4, Cortex-M23 and Cortex-M33 MCUs, enabling high-quality embedded applications for a wide range of industries.
BRITAIN is racing to invest in the stock market, a trend that has seen savings surge and boosted profits at stock brokers. Today AJ Bell said revenues for the year jumped 21% to £127 million, with profits up 29% to £49 million.
People over 80 and care home staff will be the first to be given the COVID vaccine.
Exclusive: Experiment shows hatchlings incubated in warmer sands were more likely to be eaten by ghost crabs as they crawl towards the sea
(Bloomberg) -- The U.S. House of Representatives approved legislation that could ultimately lead to Chinese companies -- including behemoths like Alibaba Group Holding Ltd. and Baidu Inc. -- getting kicked off American exchanges if regulators aren’t allowed to review their financial audits.The legislation won bipartisan support in the House after easily clearing the U.S. Senate in May. Its passage now sends the bill to President Donald Trump, who is expected to sign it, in his administration’s latest parting shot at Beijing.While the legislation provides a phase-in period -- penalties only kick in after three straight years of failure to comply -- it represents intensifying scrutiny in Washington of ties with Beijing. Chinese firms for years have relied on access to American capital markets, and more broadly to dollar-based finance, as a key funding component.“U.S. policy is letting China flout rules that American companies play by, and it’s dangerous,” said Senator John Kennedy, one of the bill’s lead sponsors, in a statement. “Today, the House joined the Senate in rejecting a toxic status quo, and I’m glad to see this bill head to the president’s desk.”Investors have mostly shrugged off the anticipated legislative move. Alibaba, the largest U.S.-listed Chinese company, was steady in after-hours trading, following a 1% drop on Wednesday. The offshore yuan was little changed. Hong Kong Exchanges & Clearing climbed 1.3% as investors bet the measure may boost the city’s role as a financing center for mainland firms.Foreign Ministry spokeswoman Hua Chunying told reporters Thursday in Beijing that China was “against politicizing securities regulation” and urged cooperation to protect investors’ rights. “It will undermine global investors’ confidence in the U.S. capital markets and will undermine the U.S. capital markets’ global standing and hurt U.S. interests,” Hua said.The development highlighted several other steps taken by the Trump administration, including an order to impound cotton from China and guidelines that would limit travel visas for 92 million Communist Party members. Any of them with a 10-year visa would now see it reduced to one month.The U.S. Department of Homeland Security said also Wednesday that customs officers at American ports would impound “shipments containing cotton and cotton products originating from” the Xinjiang Production and Construction Corps., a military-affiliated entity that’s one of China’s largest producers. This follows earlier U.S. action against the company that bar it from making any transaction with American companies and citizens.‘Cheated’ InvestorsThe legislation approved by the House represents a watershed moment in a long-running dispute between Washington and Beijing. At issue is China’s refusal to let the Public Company Accounting Oversight Board examine audits of firms whose shares trade in the U.S. The requirement for the inspections by the agency, which was created in the wake of the Enron Corp. accounting scandal, is meant to prevent fraud and wrongdoing that could wipe out shareholders.In addition to requiring companies to allow U.S. inspectors to review their financial audits, the measure -- introduced by Kennedy, a Louisiana Republican; and Senator Chris Van Hollen, a Maryland Democrat -- requires firms to disclose whether they are under government control.Van Hollen said in a statement that the delisting bill would protect people who “have been cheated out of their money after investing in seemingly legitimate Chinese companies that are not held to the same standards” as other public companies. “This bill rights that wrong, ensuring that all companies on the U.S. exchanges abide by the same rules,” he said.Read More: Market Calls Bluff on $2 Trillion Delisting Threat: China TodayFang Xinghai, the vice chairman of the China Securities Regulatory Commission, last month expressed optimism that the clash could be resolved with President-elect Joe Biden’s arrival in the White House next month. “It’s not an intractable problem,” Fang said, adding that it’s important to ensure that Chinese companies have access to international capital markets.Regulators in the two countries have been engaged in on-again, off-again negotiations amid the standoff for more than a decade. Over the years there have been moments of optimism that the two sides were closing in on a deal, but ultimately it always fell through -- with China citing strict confidentiality laws. More than 50 other foreign jurisdictions now permit the PCAOB inspections.Despite the inability of American inspectors to review audits of Chinese firms, they’ve been allowed to continue to trade in the U.S., as the dynamic has been profitable to American stock exchanges, investment banks and asset managers. According to the Securities and Exchange Commission, more than 150 of the country’s companies, with a combined value of $1.2 trillion, traded on U.S. exchanges as of 2019 and there have been a spate of initial public offerings this year.Major companies such as Vanguard Group Inc., the New York Stock Exchange, and Nasdaq have all expressed concern that the trend could reverse, with a crackdown causing Chinese companies to move their listings to Hong Kong or countries where investor protections are weaker than in the U.S. American investors would still be able to purchase the stock.Alibaba PledgeAlibaba Chief Financial Officer Maggie Wu said during a May 22 earnings call that the company “will endeavor to comply” with legislation that seeks to bring transparency to investors buying stocks on U.S. exchanges. Her comments were directed specifically at the Kennedy-Van Hollen legislation, which at that point had just passed the Senate.The bill would prohibit foreign companies from trading in the U.S. if PCAOB inspectors aren’t allowed to review their auditors’ work for three consecutive years. The businesses would also have to disclose whether they’re controlled by the Chinese Communist Party, or any other foreign government.Jay Clayton, the outgoing chairman of the Securities and Exchange Commission, said the legislation would help “level the playing field for all issuers” in the U.S. stock market. “Today’s vote, in combination the commission’s ongoing work, will help address these long-standing issues for the benefit of U.S. investors,” he said in a statement.The SEC has been pushing ahead with writing a rule to tackle the same issue, which would lead to the de-listing of companies for not complying with U.S. auditing rules, Bloomberg News reported last month. The effort is in response to recommendations released earlier this year by top Trump-appointed financial officials including Clayton and Treasury Secretary Steven Mnuchin.The NYSE said in a statement that it was “hopeful this legislation’s time horizon will allow” for balancing both protection and choice for investors. Meanwhile, Nasdaq said it “stands ready to work with our listed companies to comply with any and all regulations” and looks forward to cooperating with the SEC to bolster transparency.The bill passed on Wednesday tasks the SEC with writing a rule to implement part of the measure. As in the Senate, the bill passed the House by voice vote, underscoring the bipartisan support for the measure.(Updates with Chinese response in sixth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Dublin, Dec. 03, 2020 (GLOBE NEWSWIRE) -- The "Blood Gas and Electrolyte Analyzers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Monitoring Needs in Intensive Care Units Dramatically Spikes as COVID-19 Infections & Hospitalization Rates Increase. Blood Gas and Electrolyte Analyzers Demand Spikes by 10.1% The global market for Blood Gas and Electrolyte Analyzers is expected to spike by 10.1% in the year 2020 and continue to grow to reach US$1 billion by the year 2027, trailing a post COVID-19 CAGR of 5.1% over the analysis period 2020 through 2027. The increase in COVID-19 hospitalizations is more than counterbalancing the decline in non-COVID-19 ICU admissions due to surgery cancellations and postponement. Hospitalization rates remain high in the age group of 60 to 79 years. The overwhelming caseload of COVID-19 patients globally has burdened the healthcare system and created a pressing demand for diagnostic solutions and medical interventions. For COVID-19 patients that display signs of respiratory distress, or who are admitted in ICU units and are on ventilation support, blood gas testing is considered crucial. The assessment of damage caused due to COVID-19 in patients requires several diagnostic tests and medical interventions. While reverse transcription-polymerase chain reaction (RT-PCR) tests remain gold standard to diagnose the infection, critical care tests including blood gas and electrolyte analyzers are gaining attention among the medical fraternity for effective treatment decisions. Arterial blood gas analyzers offer measurement related to acid-base status and blood oxygenation along with gas exchange efficiency of the lungs. The device gains relevance in helping medical professionals effectively manage COVID-19 patients while making relevant treatment decisions. Arterial blood gas is a common test used for measuring blood acid and oxygenation levels along with diagnosing respiratory or renal conditions. Respiratory systems of patients are critically damaged by COVID-19 infection are hence they are unable to move oxygen inside the body and remove carbon dioxide. Also acid-base imbalance is common in patients suffering from severe viral infections, such as COVID-19. Hence accurate measurement of blood gas results is important to manage the progression of the disease in patients to assess their critical condition. The requirement to monitor these patients is driving volume demand for blood gas and electrolyte analyzers in hospitals. Blood gas and electrolyte analyzers measure various parameters from blood samples, such as pH, pCO2 and pO2, electrolytes, and metabolites. The pH value of blood and serum indicates the balance between the blood, renal, and lung systems, while the pCO2 value is used to assess the amount of carbon dioxide eliminated from the body, and the pO2 value of arterial blood indicates oxygen absorbance in the lungs. Depending on patient care scenario, physicians are relying on sophisticated critical care testing devices such as cartridge combinations of electrolytes and gases. The increasing use of these systems for point-of-care testing in laboratories and acute care venues such as COVID-19 emergency rooms, intensive care units and ambulances is boosting demand for blood gas and electrolyte analyzers. To leverage the opportunities for growth, several companies are launching advanced devices. Radiometer, a major provider of blood gas testing solutions, is offering ABL800 Flex blood gas analyzers for automated sampling and high throughput. Instrumentation Laboratory is serving healthcare needs with its advanced Gem Premier 5000 blood gas testing platform that offers automated quality with each sample. The device quickly identifies and automatically rectifies errors. While Roche Diagnostics and Nova Biomedical are offering cobas b 123 point-of-care and StatProfile pHOx Ultra systems, respectively, for enhanced throughput. On the other hand, Abbott is riding high on the popularity of its handheld i-Stat 1 blood analyzer solution for critical care that allows menu expansion for including various chemistries, electrolyte, blood gases, hematology, coagulation and cardiac markers. Epoc, a handheld wireless device from Siemens Healthineers, supports exhaustive blood analysis testing at bedside. These sophisticated solutions from vendors are anticipated to improve patient care by enabling physicians to make informed and better treatment decisions. Siemens Healthineers has secured US FDA approval for its advanced RapidPoint 500e blood gas analyzer for critical care testing. The device is intended measure electrolyte, blood gas, Co-oximetry, metabolite and neonatal bilirubin levels to aid diagnosis and monitoring of critically-ill patients in emergency rooms, intensive care units and operating rooms. Monitoring of respiratory conditions in point-of-care settings involves the use of blood gas testing devices capable of offering accurate and fast results while improving workflow efficiency. The analyzer is built on Integri-sense technology that allows automated functional checks for accurate results at point-of-care settings. In addition, RAPIDPoint 500e blood gas analyzer seamlessly integrates into hospital networks using the company's Point of Care Ecosystem for remote, convenient management of devices and operators at multiple sites. The new device holds a critical role in response efforts towards COVID-19 that depend heavily on blood gas testing for patient monitoring and management. Competitors identified in this market include, among others: * Abbott Point of Care, Inc. * Convergent Technologies GmbH & Co. KG * DALKO Diagnostics * EDAN Instruments, Inc. * Erba Mannheim * F. Hoffmann-La Roche AG * Instrumentation Laboratory, a Werfen Company * Medica Corporation * OPTI Medical Systems, Inc. * Radiometer Medical ApS * Siemens AG * Tecom Analytical SystemsKey Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1\. MARKET OVERVIEW * Impact of Covid-19 and a Looming Global Recession * Life-Saving Interventions for COVID-19 Patients Drive Importance of Blood Gas & Electrolyte Analyzers * Industry Witnesses Inflow of Sophisticated Solutions * Blood Gas and Electrolyte Analyzers: An Introduction * Types of Analyzers * Fundamentals of Blood Gases and Blood Gas Testing * Blood Gas Parameters and their Significance * Outlook * Point-of-Care Analyzers Gain Significance * Hurdles to Overcome * Competition * Recent Industry Activity * World Brands2\. FOCUS ON SELECT PLAYERS 3\. MARKET TRENDS & DRIVERS * Decentralized Testing Gains Traction * Technology Advancements: Cornerstone for Market Growth * Select New Devices * Advanced Sensors Give Way to Modern Devices * Blood Gas Testing Becomes Commonplace in Critical Care * Benchtop Makers Cash in on the Lucrative POC Market * Advanced Solutions for Point-of-Care & Critical Care Settings * Integration with LIS and EMR Widens Functionality * Miniaturised Blood Gas Analysers Gain Traction * Increasing Prevalence of Chronic Disorders and Patient admissions Fuels Market Growth * Assessment of Various Conditions Based on Blood Gas Testing * Alarming Levels of Diabetes Incidence Worldwide Drives Demand * Rise in CVD Incidence Spurs Demand * Rising Cancer Incidence and Ensuing Rise in Critical Care Admissions Create Need for Blood Gas and Electrolyte Analyzers * Rise in Prevalence of COPD Augments Demand * Rising Aging Population: Principal Driver for the BGA Market * Healthcare Cost-Cutting Trend Promotes Innovations4\. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION * Total Companies Profiled: 53For more information about this report visit https://www.researchandmarkets.com/r/vi4hfvResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
New report analyzes the future exposure of the global population, the economy, and agriculture to a range of climate hazards.
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Thursday that the extraction-free application of Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is now available in Europe. Previously in September, Seegene had CE-IVD marked this product with the sales starting in October in Europe.
HGC Global Communications Limited (HGC), a fully-fledged fixed-line operator and ICT service provider with extensive local and international network coverage, services and infrastructure, today announced the completion of its network interconnection with TKO Express to provide a more direct and resilient path between Hong Kong's major financial hub and technology centre.
Monarch is spending the festive period at the Berkshire castle for the first time in more than 30 years
The German toll services provider tolltickets, a 100% subsidiary of Kapsch TrafficCom, will expand its current footprint by providing integrated tolling services for partner companies.
Clipper Logistics has experienced its busiest ever Black Friday and posted record first-half revenues, as it benefited from the lockdown boom in online shopping. Tony Mannix, chief executive of Clipper Logistics, said “online growth has grown dramatically” this year. Clipper Logistics provides transport services for Topshop owner Arcadia, which fell into administration this week.
JinkoSolar Holding Co., Ltd ("JinkoSolar" or the "Company") (NYSE: JKS), one of the world largest and most innovative solar module manufacturers, has announced today supplied 541MW Tiger Series modules for the Phase 1 of the Xuan Thien Ea Sub project in Dak Lak Province, Vietnam.
Rather than isolating and wearing masks, many are gathering for holiday meals and ignoring state restrictions. The strain on the health system is real.
DoorDash will allow restaurants that prefer using their own people for delivery to use its platform to reach more potential customers. DoorDash says the option could increase restaurants’ visibility in their area while being in control of their “end-to-end customer experience” and creating “new opportunities for their existing staff.” Restaurants that sign up under the option can set a delivery zone and price their own delivery fees.